Thursday 3 March 2022 6:00pm to 7:45pm
About
Open to all scientists researching new therapeutics in Cambridge and the local area.
The purpose of the CamNTF is to promote interactions between scientists from academia & industry in order to improve opportunities for biotechnology research and development. Meeting attendance is free but all attendees must register in advance.
Next event:
Host: EMBL’s European Bioinformatics Institute (EMBL-EBI)
Date: Thursday 3rd March
Location: This event will take place online. Please register on Eventbrite and joining details will be circulated prior to the event.
Programme
18:00 – Welcome: Dr Matt Hall, Industry Partnerships, EMBL-EBI
Session Chair: Dr Ellen McDonagh, Informatics Science Director, Open Targets, EMBL-EBI
18:10 – Dr Maya Ghoussaini, Genetic Analysis Team Leader, Open Targets, Wellcome Sanger Institute
Talk title: “Open Targets Genetics: An atlas of trait-associated loci to guide target prioritization”
18:40 – Dr Andrew Leach, Head of Industry Partnerships and Head of Chemical Biology, EMBL-EBI
Talk title: “Target tractability and the PROTACtable genome”
19:10 – Dr Andrew Bassett, Head of Cellular and Gene Editing Research Group, Wellcome Sanger Institute
Talk title: “Validating causal variants in pluripotent stem cells using GenIE”
19:45 – Meeting close
Event registration: https://camntfmarch2022.eventbrite.co.uk/